Maintenance Programme After Weight Loss
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00590655|
Recruitment Status : Completed
First Posted : January 10, 2008
Last Update Posted : January 10, 2008
|Condition or disease||Intervention/treatment|
|Weight Loss Morbid Obesity||Behavioral: weight loss programme with maintenance programme Behavioral: weight loss programme|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||201 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Maintenance Programme on the Long Term Weight Reduction in Severely Obese Patients. A Randomized Controlled Trial|
|Study Start Date :||August 2002|
|Study Completion Date :||May 2006|
Active Comparator: 2
Treatment B includes a four month weight loss programme (10 weeks on a VLED and 17 weeks behavior modification visits). Treatment lasts 17 weeks and after that there will be one and two year control visits including weighing and questionnaires for eating behavior and quality of life.
|Behavioral: weight loss programme|
Treatment includes a four month weight loss programme (10 weeks on a VLED and 17 weeks behavior modification visits). After that a maintenance programme starts with monthly sessions for one year. Weight loss, quality of life, and eating behavior will be assessed at the end of the maintenance program and one year later.
Behavioral: weight loss programme with maintenance programme
After usual weight loss treatment, there will be a one-year maintenance programme with monthly visits.
- weight result [ Time Frame: 2 years after weight loss phase ]
- quality of life and eating behavior [ Time Frame: 2 years after active weight loss ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00590655
|Vantaa, Finland, 01400|